Authors: Vanisha Patel1,*, Maciej Kabat1, Andrew Ip2, Sukhdeep Kaur2, Hyung Chan Suh2, Christina Cho2, David Vesole2, Michele Donato2, Maher Albitar2, Scott D. Rowley2 Affiliations:1Hackensack University Medical Center, Hackensack, New Jersey2John Theurer Cancer Center, Hackensack, New Jersey Article history: Received 9 May 2025 | Accepted 11 August 2025 Abstract Allogeneic stem cell transplantation
Authors: Vanisha Patel1,*, Maciej Kabat1, Andrew Ip2, Sukhdeep Kaur2, Hyung Chan Suh2, Christina Cho2, David Vesole2, Michele Donato2, Maher Albitar2, Scott D. Rowley2 Affiliations:1Hackensack University Medical Center, Hackensack, New Jersey2John Theurer Cancer Center, Hackensack, New Jersey Article history: Received 9 May 2025 | Accepted 11 August 2025 Abstract Allogeneic stem cell transplantation
Authors: Vanisha Patel1,*, Maciej Kabat1, Andrew Ip2, Sukhdeep Kaur2, Hyung Chan Suh2, Christina Cho2, David Vesole2, Michele Donato2, Maher Albitar2, Scott D. Rowley2 Affiliations:1Hackensack University Medical Center, Hackensack, New Jersey2John Theurer Cancer Center, Hackensack, New Jersey Article history: Received 9 May 2025 | Accepted 11 August 2025 Abstract Allogeneic stem
GTC Expands Cancer Tests to Europe via Partnership By Yuika Yoshida April 7, 2025 Genomic Testing Cooperative (GTC) is expanding into the European market by partnering with German laboratory Labor Dr. Wisplinghoff. “Our diagnostics tests going out of the U.S. to Europe is democratizing science,” Chief Executive Dr. Maher Albitar told the
